Filter
1273
Text search:
drug
reaction
Featured
159
368
Language
Document type
853
182
106
57
23
21
20
4
4
2
1
Countries
92
38
34
34
33
30
30
28
25
23
23
22
18
16
15
15
15
15
13
12
12
11
10
10
9
9
9
8
8
8
7
6
6
6
5
5
4
4
4
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
510
184
46
38
30
24
13
Toolboxes
140
115
113
75
59
55
39
30
29
28
21
14
9
8
8
8
8
7
7
6
5
2
2
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Accessed November 2017
WHO/CDS/TB/99.272
Key populations brief.
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
J HEALTH POPUL NUTR 2010 Aug;28(4):327-332
ISSN 1606-0997
A guide to protocol development for low-income countries
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016